Congress Trades in IDEXX Laboratories, Inc. (IDXX)

8 members of Congress have disclosed trading IDXX.

Total trades
11
Purchases
6
Sales
5
Members
8
Est. volume
$255,000
Last traded
Sep 4, 2025
Want the fundamentals on IDXX?
See IDEXX Laboratories, Inc.'s price, P/E, ROE and a free return calculator.
IDXX stock analysis →

8 members of Congress have disclosed trading IDEXX Laboratories, Inc. (IDXX), with 11 transactions in total — 6 purchases and 5 sales worth an estimated $255,000 at range midpoints, leaning toward buying. The most active IDXX trader is April McClain Delaney (3 disclosures). The most recent disclosed IDXX trade was on Sep 4, 2025. See our full IDXX fundamentals page for price, valuation and a return calculator.

Every disclosed IDXX trade

DisclosedPoliticianTypeAmountTraded
Oct 1, 2025 Byron Donalds R Purchase $1,001 - $15,000 Sep 4, 2025 filing ↗
May 15, 2025 Jefferson Shreve R Sale $100,001 - $250,000 May 12, 2025 filing ↗
May 1, 2025 April McClain Delaney D Purchase $1,001 - $15,000 Apr 9, 2025 filing ↗
May 1, 2025 April McClain Delaney D Purchase $1,001 - $15,000 Apr 4, 2025 filing ↗
Apr 1, 2025 April McClain Delaney D Purchase $1,001 - $15,000 Mar 14, 2025 filing ↗
Feb 25, 2025 Rob Bresnahan Purchase $1,001 - $15,000 Feb 25, 2025 filing ↗
Feb 19, 2021 Peter Meijer Sale $1,001 - $15,000 Feb 16, 2021 filing ↗
Mar 7, 2019 Gilbert Cisneros D Purchase $1,001 - $15,000 Feb 26, 2019 filing ↗
Jul 1, 2015 Lamar Smith Sale $1,001 - $15,000 Jun 2, 2015 filing ↗
Feb 13, 2015 K. Michael Conaway Sale $1,001 - $15,000 Feb 10, 2015 filing ↗
Apr 1, 2014 Lamar Smith Sale $1,001 - $15,000 Mar 11, 2014 filing ↗

Most active IDXX traders in Congress

April McClain Delaney April McClain Delaney Democrat 3 trades LS Lamar Smith 2 trades Byron Donalds Byron Donalds Republican 1 trade Jefferson Shreve Jefferson Shreve Republican 1 trade RB Rob Bresnahan 1 trade PM Peter Meijer 1 trade Gilbert Cisneros Gilbert Cisneros Democrat 1 trade KM K. Michael Conaway 1 trade

Source: US House Clerk Periodic Transaction Reports. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Not investment advice.